Pharmacotherapy Effects on Smoking Cessation Vary with Nicotine Metabolism Gene (CYP2A6)

類似資料

• Genetic Variation (CHRNA5), Medication (Combination Nicotine Replacement Therapy vs. Varenicline) and Smoking Cessation()
  著者:: Chen, Li-Shiun, 等
  出版事項: (2015)
• CYP2B6 Non-Coding Variation Associated with Smoking Cessation Is Also Associated with Differences in Allelic Expression, Splicing, and Nicotine Metabolism Independent of Common Amino-Acid Changes
  著者:: Bloom, A. Joseph, 等
  出版事項: (2013)
• The Effect of Five Smoking Cessation Pharmacotherapies on Smoking Cessation Milestones
  著者:: Japuntich, Sandra J., 等
  出版事項: (2011)
• Variants in two adjacent genes, EGLN2 and CYP2A6, influence smoking behavior related to disease risk via different mechanisms
  著者:: Bloom, A. Joseph, 等
  出版事項: (2014)
• Nicotine vaccines for smoking cessation
  著者:: Hartmann‐Boyce, Jamie, 等
  出版事項: (2012)